Loeb Says Amgen Has Multiple Personalities, Should Be Broken Up; Company 'Appreciates' Input

Mark Melin

Published onOctober 22, 2014

Updated on May 13, 2021

Daniel Loeb's hedge fund, Third Point LLC, might think its latest investment, Amgen, Inc. (NASDAQ:AMGN), has a multiple investment personality disorder.

Loeb divides Amgen into two distinct companies

In a letter to investors Loeb recommended the company be divided into two distinct companies: one a fast growing growth company, well suited for the active, momentum traders; and a second company, the mature growth company, that delivered solid dividends to shareholders.

The Third Point letter even nicked named the companies GrowthCo and MatureCo, each appealing to a different investor segment....

Login required to continue reading.

Setup a free account to get access to this article (no credit card required).

View Full Article

Already a member? Log in here

Mark Melin

Mark Melin is an alternative investment practitioner whose specialty is recognizing the impact of beta market environment on a technical trading strategy. A portfolio and industry consultant, wrote or edited three books including High Performance Managed Futures (Wiley 2010) and The Chicago Board of Trade’s Handbook of Futures and Options (McGraw-Hill 2008) and taught a course at Northwestern University's executive education program.

Loeb Says Amgen Has Multiple Personalities, Should Be Broken Up; Company 'Appreciates' Input

Loeb divides Amgen into two distinct companies

Login required to continue reading.

Get Your Business News